La
oficina de proyectos
internacionales del IIS
Aragón ha creado este
boletín mensual mediante
el cual se va a informar
de las convocatorias de
proyectos que se
encuentran abiertas, los
eventos y las jornadas que
puedan resultar
interesantes al respecto
para el personal
investigador y de
gestión.
Si quieres contactar con
la oficina de proyectos
internacionales puedes
hacerlo a través de esta
dirección de correo
electrónico:
internacional@iisaragon.es
The
ISIDORe project
proposes to fund
Research &
Development into
preparedness and
responsiveness, by
giving scientific
communities, free-of-charge
transnational
access (TNA)
to the whole extent
of our
state-of-the-art
facilities,
cutting-edge
services, advanced
equipment and
technologies, made
available through
our catalogue of
services.
The
first aim of the
Networking Support
Scheme in the
European Joint
Programme on Rare
Diseases (EJP RD) is
to encourage sharing
of knowledge on rare
diseases or rare
cancers between
health care
professionals,
researchers and
patients in new or
expanding research
networks by funding
networking events.
The second aim of
the Networking
Support Scheme is to
enable or increase
the participation of
usually
underrepresented
countries in Europe
in new and in
expanding research
networks on rare
diseases or rare
cancers.
The scheme will
provide financial
support to
applicants to
organize workshops
or conferences.
These workshops or
conferences are
meant to
1. Form new research
networks or expand
existing research
networks;
2. Strengthen
collaborations
between different
stakeholders in
different countries;
3. Enable the
exchange of
knowledge.
4. These workshops
or conferences
should be (the
implications of)
research results and
innovative
solutions. The
results of these
networking events
may lead to future
collaborative and
novel research
efforts.
Open
Calls for
TRANSVAC2 Vaccine
Development
Trainings
TRANSVAC2,
which EATRIS is a
partner in, is now
running additional free
training courses
to provide
fundamental and
advanced knowledge
on a wide range of
vaccine
development-related
topics, including
another chance to
join the successful
EATRIS Vaccine
Regulatory training
course.
On this call
TRANSVAC2 offers
free three advanced
courses:
IARC
Summer School 2023
Call for
Applications is
Open
The
International Agency
for Research on
Cancer (IARC) is
pleased to announce
that it is now
accepting
applications for the
IARC Summer School
2023, for two
modules:
"Introduction to
Cancer Epidemiology"
and "Implementing
Cancer Prevention
and Early
Detection".
The IARC Summer
School 2023 provides
the opportunity to
stimulate cancer
research, improve
scientific
knowledge, and
develop
collaborations among
researchers
worldwide. Building
on past successful
IARC Summer Schools,
the two modules in
2023 will be
delivered as blended
training programmes,
combining online
learning with
virtual and
in-person classes.
The hybrid format
will offer the best
of remote learning
and the unmatched
value of
relationships formed
during face-to-face
events and their
effect on boosting
network-building and
future
collaborations.
Those who want to
attend the summer
school module on
"Implementing Cancer
Prevention and Early
Detection" should
first take the
self-paced course on
cancer prevention
and early detection,
which is available
on the IARC Learning
portal. This
self-paced learning
path will take
participants through
various resources,
which cover the
basic concepts and
principles related
to cancer prevention
and early detection.
See the links below
for more
information.
Horizon
Europe – ERC Proof
of Concept Grant
(ERC-2023-POC)
Horizon
Europe – ERC Proof
of Concept Grant
(ERC-2023-POC)
The ERC Proof of
Concept Grants aim
at facilitating
exploration of the
commercial and
social innovation
potential of ERC
funded research, by
funding further work
(i.e. activities
which were not
scheduled to be
funded by the
original ERC
frontier research
grant) to verify the
innovation potential
of ideas arising
from ERC funded
projects. Proof of
Concept Grants are
therefore on offer
only to Principal
Investigators whose
proposals draw
substantially on
their ERC funded
research.
The financial
contribution will be
awarded as a lump
sum of EUR 150 000
for a period of 18
months.
The ERC expects
that, normally,
proof of concept
activities should be
completed within 12
months. However, to
allow for those
projects that
require more
preparation time,
the grant agreements
will be signed for
18 months.
Extensions of the
duration of proof of
concept projects may
be granted only
exceptionally.The
lump sum will cover
the beneficiaries'
direct and indirect
eligible costs for
the project: if the
project is
implemented
properly, the
amounts will be paid
regardless of the
costs actually
incurred. The lump
sum has been
designed to cover
the beneficiaries’
personnel costs,
subcontracting,
purchase costs,
other cost
categories, and
indirect costs.
All Principal
Investigators in
an ongoing ERC
main grant or in a
ERC main grant
that has ended
less than 12
months before 1
January 2023,
are eligible to
apply for an ERC
Proof of Concept
Grant.
ATTRACT-Call:
Accelerate
Together Rare
Cancer Treatment
Cinco
fondos europeos
contra el cáncer,
entre los que se
encuentra la
Fundación Científica
de la Asociación
Española Contra el
Cáncer, se unen para
estimular la
investigación
internacional para
el desarrollo de
fármacos contra
cánceres raros.
Esta convocatoria
internacional
conjunta,
ATTRACT-Call, se
centra en ensayos
clínicos de fase 2/3
de medicamentos
contra cánceres
raros, y cuenta con
11,5 M€ de
presupuesto.
Objetivos:
- Mejorar el
tratamiento de los
cánceres raros
- Llevar los
fármacos a la
siguiente fase de
Desarrollo
Horizon
Europe – ERC
Consolidator Grant
(ERC-2023-COG)
The
ERC Consolidator
Grants are designed
to support excellent
Principal
Investigators at the
career stage at
which they may still
be consolidating
their own
independent research
team or programme.
Principal
Investigators must
demonstrate the
ground-breaking
nature, ambition and
feasibility of their
scientific proposal.
Consolidator Grants
may be awarded up to
a maximum of EUR
2 000 000
for a period of 5
years.
The maximum size of
the grants is
reduced pro rata
temporis for
projects of a
shorter duration.
(This does not apply
to ongoing
projects).
The Principal
Investigators shall
have been awarded
their first PhD at
least 7 and up to
12 years prior to
1 January 2023.
Cut-off dates: PhD
awarded from 1
January 2011 to 31
December 2015
(inclusive).
Pre-anuncio
de Convocatoria de
Proyectos
Transnacionales con
participación de la
Agencia Estatal de
Investigación en el
marco de “ERA4Health
Partnership”.
España participa en
la segunda
convocatoria
transnacional de la
iniciativa
ERA4Health
Partnership
“Fostering a
European Research
Area for Health”, a
través de la Agencia
Estatal de
Investigación (AEI),
el Instituto de
Salud Carlos III
(ISCIII) y la
Consejería de Salud
y Consumo de la
Junta de Andalucía
(CSCJA). Esta
iniciativa lanzará
una convocatoria el
7 de
diciembre de 2022.
El objetivo general
de la convocatoria
es apoyar la
investigación
transversal que
contribuya al
desarrollo de estrategias
de innovación
terapéutica en
enfermedades
cardiovasculares,
abordando alguna (o
ambas) de las
siguientes áreas de
investigación:
1- Reparación y/o
regeneración del
corazón y/o de los
vasos sanguíneos.
2-Insuficiencia
cardíaca crónica y
fibrilación
auricular.
MSCA
COFUND co-finances
new or existing
doctoral programmes
and postdoctoral
fellowship schemes
with the aim of
spreading the best
practices of the
MSCA including
international,
inter-sectoral and
interdisciplinary
research training,
as well as
international and
cross-sectoral
mobility of
researchers at all
stages of their
career.
In practice, MSCA
COFUND provides
complementary
funding for doctoral
or postdoctoral
programmes managed
by entities
established in EU
Member States or
Horizon Europe
Associated
Countries. Those
co-funded programmes
must follow MSCA’s
good practice in
terms of
international
recruitment and
minimum standard of
employment for the
recruited fellows as
described in the
European Charter for
Researchers and Code
of Conduct for the
Recruitment of
Researchers.
Opening date:
11/10/2022
EU4H-2022-PJ-11:
Call for proposals
on prevention of
NCDs -
cardiovascular
diseases, diabetes
and other NCDs EU4H-2022-PJ-12:
Call for proposals
on cancer and other
NCDs prevention –
action on health
determinants EU4H-2022-PJ-14:
Call for proposals
to support the
roll-out of the
second cohort of the
inter-speciality
cancer training
programme
MSCA
Staff Exchanges
promote innovative
international,
inter-sectoral and
interdisciplinary
collaboration in
research and
innovation through
exchanging staff and
sharing knowledge
and ideas at all
stages of the
innovation chain.
The scheme fosters a
shared culture of
research and
innovation that
welcomes and rewards
creativity and
entrepreneurship and
helps turn ideas
into innovative
products, services
or processes. It is
open to research,
technical,
administrative, and
managerial staff
supporting R&I
activities.
RARE2022 will follow on
from the success of its
predecessors, continuing
to address the challenges
of Rare Diseases. The
conference will expand on
“generic topics”, such as:
the
role of whole genome
sequencing
screening
strategies
monitoring
and databases in rare
diseases
innovative
therapies
patient-centric
medicine
current
status of several
specific diseases
RARE2022
is honored to welcome
world-renowned speakers
from all 5 continents, all
of whom are experts in the
field of Rare Diseases and
who will present
ground-breaking and
cutting-edge news on
treatments in Rare
Diseases.
RARE2022 will bring
together experts from
healthcare, academia and
industry working in the
field of Rare Diseases
treatment.
“Research
targeting development of
innovative therapeutic
strategies in
cardiovascular disease”
(CARDINNOV)
Following the recent
pre-announcement of the
CARDINNOV call, on
research targeting
development of innovative
therapeutic strategies in
cardiovascular disease,
ERA4Health invite all
potential project
applicants to an info day
and matchmaking event.
The Call documents and
guidelines to how apply
will be presented. In this
event, ERA4Health will
also network applicants
who are looking for an
additional expertise in
their consortium or look
for integrating a
consortium.
For participation please
register before the 8th
December. Additional
information will be sent
to people who registered.
The
aim of the IHI Call Days
is to provide potential
applicants with the
information they need to
put together a strong
proposal and give them the
opportunity to identify
and meet partners for
their consortia.
The main activities of the
Call Days will be as
follows:
Info
sessions on the rules and
procedures and financial
part of the proposal
The
aim of the IHI Call Days
is to provide potential
applicants with the
information they need to
put together a strong
proposal and give them the
opportunity to identify
and meet partners for
their consortia.
The main activities of the
Call Days will be as
follows:
Registration
is now open to the yearly
5-day course on
“Translational Medicine
Explained (TMex) ” on 13-17
February 2023 in
Barcelona.
The course is intended for
PhD/MD students, postdocs
and other young scientists
who are involved in
biomedical research and
want to learn more about
Translational Medicine.
The TMex (“Translational
Medicine Explained)”
Winter School consists of
an introductory e learning
(~12 hours student
investment time) followed
by a 5-day face-to-face
workshop. The course is
intended for PhD/MD
students in the second
half of their PhD and
postdocs who are involved
in biomedical research.
The full fee is of 650€.
Special discounted fees of
475€ applies for EATRIS
members and I2TRON
students, and of 250€ for
VHIR students and EUPATI
fellows.
There are only 30 seats,
so we recommend applying
early (first come, first
served). The
registration will
close when all seats
have been filled.
You will need to submit a
biosketch and a motivation
letter which will be
reviewed by a selection
committee.
Contacto
Instituto de Investigación
Sanitaria Aragón (IIS Aragón)
Centro de Investigación
Biomédica de Aragón (CIBA)
Avda. San Juan Bosco, nº 13.
50009 - Zaragoza
Tfno. +34 976 71 64 17 | +34 976
71 44 02
Recibes este boletín porque eres
miembro del IIS Aragón o porque
estás interesado en sus
actividades. Si no deseas
recibirlo, por favor, ponte en
contacto con internacional@iisaragon.es
para tramitar la baja de la
suscripción.
